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Abstract 
Background: Oral tongue squamous cell carcinoma (OTSCC) is still associated with a poor prognosis due to local 
recurrence and metastasis. Cancer‑associated fibroblasts (CAFs) play an important role in the complex processes of 
cancer stroma interaction and tumorigenesis. This study aims to determine the role of CAFs in the development and 
progression of OTSCC.
Methods: Immunohistochemistry was performed to evaluate the frequency and distribution of CAFs in 178 paraffin 
specimens from patients with OTSCC. Immunofluorescence, a cell proliferation assay, flow cytometry, migration and 
invasion assays and western blot analysis were used to study the effects of CAFs and the corresponding conditioned 
medium (CM) on the proliferation and invasion of OTSCC cell lines.
Results: Statistical analysis showed a strong correlation between the frequency and distribution of CAFs and the clin‑
icopathological characteristics of patients with cN0 OTSCC, including pathological stage (P = 0.001), T classification 
(P = 0.001), and N classification (P = 0.009). Survival analysis demonstrated a negative correlation of the frequency 
and distribution of CAFs with the overall survival and disease‑free survival of patients with cN0 tongue squamous cell 
cancer (P = 0.009, 0.002, respectively); Cox regression analysis showed that the presence of CAFs (relative risk: 2.113, CI 
1.461–3.015, P = 0.023) is an independent prognostic factor. A functional study demonstrated that CAFs and CM from 
CAFs could promote the growth, proliferation, mobility, invasion and even Epithelial Mesenchymal Transition (EMT) of 
OTSCC cells compared with NFs and CM from NFs.
Conclusions: CAFs were an independent prognostic factor for patients with OTSCC. Compared with NFs, CAFs and 
their CM have the ability to promote the growth, proliferation, metastasis and even EMT of OTSCC cells.
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Background
Oral cancer is the tenth most commonly diagnosed can-
cer in men worldwide and accounts for 263,900 cases 
worldwide [1]. The tongue is the most cancer-prone 
intraoral site in most populations that have been studied, 
and the most common pathological type of oral tongue 
cancer is squamous cell cancer [2]. Although intensive 
efforts have been made in primary prevention and in the 
improvement of therapy, the morbidity and mortality 
rates for oral tongue cancer remain steady and high and 
have even continued to rise in some developing coun-
tries. Due to its highly invasive nature, oral tongue squa-
mous cancer frequently leads to severe defects in speech, 
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mastication and deglutition, as well as cancer-related 
death. During the last three decades, the long-term sur-
vival rate for patients with oral tongue cancer has not 
improved substantially, and the tongue remains among 
the worst sites for all cancers with respect to survival [3].
Cancer has long been considered a cell-autonomous 
process in which progressive genetic and epigenetic 
alterations transform cells independently of the external 
milieu. Substantial evidence indicates that the interac-
tions between tumor cells and their microenvironment 
are of great importance in the development and pro-
gression of cancer. Cancer cells may alter the surround-
ing cancer stroma and, in turn, cancer stromal cells and 
cytokines may promote cancer progression and the 
acquisition of invasive properties [4, 5].
According to new data that have accrued, the cancer 
stroma can be described as an active microenvironment 
that modulates the biology of the carcinoma including 
cancer stem cells [6]. The cancer stromal portion of a car-
cinoma is formed by the interaction of cancer stromal cells 
and cytokines in the extracellular matrix, which is pro-
duced by fibroblasts, macrophages and other inflamma-
tory cells as well as blood/lymphatic capillaries [7]. Recent 
progress in cancer biology has markedly changed our view 
with regards to the functional significance of the cancer 
stroma. A sub-population of cells in the cancer stroma, 
with a myofibroblast-like phenotype, has been termed 
cancer-associated fibroblasts (CAFs) [8, 9]. In the can-
cer stroma, CAFs undergo changes in protein expression 
that represent an ‘activated’ myofibroblastic phenotype, 
which typically involves the up-regulation of markers such 
as α-smooth muscle actin (α-SMA) [10, 11]. By imitating 
activated ‘wound repair’ fibroblasts, CAFs are thought to 
promote the progression of carcinoma via the stimulation 
of epithelial cell growth, migration and invasion [5, 12, 13].
CAFs represent an additional histopathologic fea-
ture and are of great importance in the complex cancer 
stroma. It was reported that CAFs are derived from nor-
mal cancer stromal fibroblasts under the direct impact 
of cancer cell-derived cytokines and function to further 
facilitate local and distant migration as well as aid in 
the suppression of the host immune response [14–16]. 
In addition, emerging evidence has also shown that the 
malignant epithelial cells themselves may be a significant 
source of CAFs [14, 17]. This phenomenon is termed epi-
thelial–mesenchymal transition (EMT), during which 
epithelial cells lose their specific markers and acquire the 
characteristics of mesenchymal cells [18, 19].
A recent study on human tongue carcinogenesis 
showed that CAFs emerged concomitantly with the 
development of carcinomas, but were practically absent 
in dysplastic, pre-malignant lesions [20]. CAFs have a dis-
tinctive phenotype compared with quiescent fibroblasts 
in differentiated adult tissue, but the morphologic and 
functional differences are not completely understood. 
Gene expression profiling by cDNA microarray technol-
ogy can vastly aid in the characterization of CAFs that 
are isolated from a broad range of solid tumors, includ-
ing pancreatic [21], colon [22], breast [23], and basal cell 
cancers [24].
Studies of different cancer types have shown that CAFs 
are located in the vicinity of tumor cells and are able to 
enhance tumor growth through the secretion of growth 
factors (e.g., transforming growth factor-μ), matrix 
degrading enzymes [e.g., matrix metalloproteinases 
(MMPs)], and angiogenic factors (e.g., vascular endothe-
lial growth factor) [25–30]. This study aims to determine 
the role of CAFs in the development and progression 
in oral tongue squamous cell carcinoma (OTSCC) and 
to reveal the characteristics of gene expression in CAFs 
compared with NFs.
Methods
Patients, tissue specimens and cell lines
The specimens were used after prior written consent was 
obtained from the patients as well as after the approval 
of the Institutional Research Ethics Committee of the 
Sun Yat-sen University Cancer Center. A total of 178 tis-
sue specimens were removed from patients with cN0 oral 
tongue cancer, none of whom had received radiotherapy 
or chemotherapy prior to surgery. Sixty years of age was 
selected as the cut-off point because it is the mean age 
of the overall patient population with oral SCC [31]. 
Patient progress was followed for 78.3  ±  42.1  months 
(mean ±  SD). The clinical characteristics of this patient 
cohort are summarized in Additional file 1: Table S1.
Eight pairs of primary OTSCC tissues and surrounding 
nontumor oral tongue tissues were collected at the time 
of surgical resection at the Cancer Center of Sun Yat-sen 
University. None of the patients received adjuvant ther-
apy prior to surgery.
Four human oral tongue cancer cell lines were pur-
chased from the American Type Culture Collection 
(SCC-25 and CAL-27) and the Cell Bank of Type Culture 
Collection of the Chinese Academy of Sciences (TSCCa 
and Tca-8113). All cells were grown in 5% CO2 in a 
humidified atmosphere at 37°C.
Immunohistochemistry
With regards to the double immunostaining, one addi-
tional section from each case was subjected to a stain-
ing protocol that combined two markers: α-SMA and 
Ki-67. Sections were pre-treated with an EDTA buffer 
at pH 9 and heated in a pressure cooker. Sections were 
then exposed to a mixture of antibodies against Ki-67 
(polyclonal, 1:50, Dako, Denmark) and α-SMA (clone 
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1A4, 1:100, Dako, Denmark) and incubated for 1  h at 
room temperature. Then, the sections were treated with 
MACH 2 double stain polymer detection kit #2 (mouse-
HRP  +  rabbit) alkaline phosphatase (ALP)) (Biocare 
Medical, Concord, CA, USA), followed by 3,3′-diamino-
benzidine (DAB), Vulcan Fast Red chromagen kit 2 
(Biocare Medical, USA), and denaturing solutions A 
and B (Biocare Medical, USA). Afterwards, the sec-
tions were treated with MACH2 polymer-ALP conju-
gate (goat antimouse polymer-ALP secondary antibody) 
(Biocare Medical, USA). This was followed by treatment 
with Ferangi Blue chromagen system (Biocare Medical, 
USA). Finally, the slides were covered by GVA mounting 
medium (Zymed, San Francisco, CA, USA). As a result, 
the nuclear staining of Ki-67 was visualized as a red fuch-
sin color, while the cytoplasmic staining of α-SMA was 
brown. Special emphasis was placed upon the assessment 
of the relationships between the tumor cells and the adja-
cent CAFs at the tumor–host interface.
The immunohistochemically stained slides were exam-
ined for the pattern of distribution of CAFs throughout 
the entire cancer stroma [32].
Quantitatively, the number of CAFs was assessed on 
a 5-scale scoring system: 0, devoid of CAFs; 0.5, a few 
CAFs with a spindle-shaped morphology that adhered 
closely to the periphery of the SCC islands/nests; 1, 
CAFs surrounded the tumor in a few concentric layers 
in several foci; 2, CAFs with both a spindle-shaped and 
a plump morphology were observed in many areas of the 
tumor; 3, similar to a score of “2”, but CAFs were excep-
tionally abundant throughout the section and occasion-
ally exceeded the carcinomatous component (Figure  1). 
For the purpose of statistical analysis, cases with low 
scores (0, 0.5, and 1) were combined and compared with 
cases with high scores (2 and 3).
Isolation of fibroblasts
Cancer tissue and its paired normal oral tongue tis-
sue were cut into the smallest pieces possible in sterile 
PBS solution and were then digested with collagenase 
(0.1% collagenase type IV, Sigma) at 37°C for 30  min. 
The suspension was filtered through a 20-μm stain-
less steel wire mesh to collect a single-cell suspension. 
The filtrate was centrifuged at 1,500 rpm for 5 min and 
washed twice with DMEM before the cells were plated 
on 6-cm tissue culture dishes in 5 mL DMEM supple-
mented with 20% fetal bovine serum. After 30 min in 
culture at 37°C, the nonadherent cells (mainly tumor 
cells) were removed to obtain a population of pure 
fibroblasts because the adhesion time needed for 
fibroblasts is much shorter (20–30  min) than that for 
tumor cells (usually >1  h). The adherent fibroblasts 
were sub-cultured for further study.
Immunofluorescence
Cells were grown on gelatin-coated coverslips for 24  h 
and then fixed in 4% paraformaldehyde at room tempera-
ture for 20  min. Cells were incubated with PBS-B solu-
tion at 37°C for 30 min to block nonspecific interactions 
and were then incubated overnight at 4°C with various 
ready-to-use primary antibodies against fibronectin, 
E-cadherin, α-SMA. After several washes in PBS, the cells 
were incubated with optimal concentrations of FITC-
labeled secondary antibody (Dako) at room temperature 
for 1 h. Antifade 4′,6-diamidino-2-phenylindole solution 
was added, and images were obtained.
Detection of DNA content by flow cytometry
In regard to the flow cytometric analysis, 1–2  ×  106 
cells were fixed in 70% ethanol and stained with propid-
ium iodide. The DNA content was then analyzed with a 
Cytomics FC device (Beckman Coulter). Finally, the cell 
cycle profiles were analyzed with Modfit LT2.0. To deter-
mine the ploidy pattern of the tested cells (CAFs, NFs, 
and cancer cells), a DNA index was calculated based as 
the ratio of the G1 peak channel of the tested cells to the 
G1 peak channel of normal peripheral blood lympho-
cytes. All experiments were performed independently 
and in triplicate.
Cell growth assay
The cell growth rates of fibroblasts derived from OTSCC 
tissue and normal tissue were determined by 2,3-Bis-
(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-
5-carboxanilide (XTT) assay. Cells were seeded into 
96-well plates at a density of 1 × 103 per well. The XTT 
kit (Sigma) was used according to the manufacturer’s 
instructions. All experiments were performed indepen-
dently and in triplicate.
Effect of fibroblasts on the growth and migration  
of OTSCC cells
A 3-D culture was performed to examine the effect of 
fibroblasts on the growth and migration of OTSCC 
cells. CAFs, NFs, TSCCa or CAL-27 cells were seeded 
into 24-well plates that were coated with 50 μl BioCoat 
Matrigel at a density of 5.0 × 103 per well. CAFs or NFs 
were added to eight plates with TSCCa or CAL-27 cells 
plated at a density of 2.0  ×  103 per well. We observed 
the aggregation of the cells after 1 week of culture in 5% 
CO2 in a humidified atmosphere at 37°C. All experiments 
were performed independently and in triplicate.
Preparation of the conditioned media
OTSCC cells (TSCCa and CAL-27) and fibroblasts (CAFs 
and NFs) were seeded into T75 culture flasks and grown 
in normal growth media (10  mL of DMEM with 10% 
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fetal bovine serum) for 48 h until the cells were approxi-
mately 80% confluent. The culture medium was then col-
lected from each flask and centrifuged at 1,000  rpm for 
30 min, and the supernatant was collected as conditioned 
medium (CM) for further study.
Effect of CM from fibroblasts on the growth of OTSCC cells
To examine the effect of CM from fibroblasts on the 
growth of OTSCC cells, TSCCa or CAL-27 cells were 
seeded into 96-well plates at a density of 1.5 × 103 per well 
and cultured in CM from CAFs and NFs. CM from TSCCa 
or CAL-27 cells was used as a control. The cell growth rate 
was determined by XTT assay as described previously. 
Independent experiments were performed in triplicate.
Effect of CM from fibroblasts on the migration of ESCC cells
Cell mobility was assessed by a scratch wound-healing 
assay. TSCCa or CAL-27 cells were grown to confluence in 
a six-well plate with normal growth medium. The cell mon-
olayer was mechanically scratched with a sterile pipette 
tip. Subsequently, the cells were incubated with CM from 
CAFs or NFs instead of normal growth medium. CM from 
TSCCa or CAL-27 cells was used as a control. Cell mobility 
in terms of wound closure was measured by imaging three 
random fields at the time points 0, 24 and 48 h.
Effect of CM from fibroblasts on the invasiveness  
of ESCC cells
An invasion assay was performed with a BioCoat 
Matrigel Invasion Chamber (BD Biosciences) accord-
ing to the manufacturer’s instructions. Briefly, TSCCa 
or CAL-27 cells (2.5  ×  105) were placed in the upper 
compartment of each chamber. The lower compartment 
was filled with CM from TSCCa cells (or CAL-27 cells), 
CAFs, or NFs. After 24 h, cancer cells that had penetrated 
the Matrigel-coated membrane and passed into the lower 
Figure 1 Representative double immunohistochemical images of cN0 oral tongue cancer tissue specimens, which indicate high frequency and 
distribution of CAFs (a) and low frequency and distribution of CAFs (b). Tumor cell nuclei are stained a brown with the Ki‑67 antibody, whereas 
CAFs are stained a fuchsin color in the cytoplasm by the α‑SMA antibody. Magnification is ×200 (a, b). The frequency and distribution of CAFs affect 
overall survival and disease‑free survival. Kaplan–Meier curves with univariate analysis (log‑rank) for patients with cN0 oral tongue cancer with a 
high frequency and distribution of CAFs (n = 95) versus a low frequency and distribution of CAFs (n = 83) with respect to overall survival (c) and 
disease‑free survival (d).
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compartment were stained and counted. Independent 
experiments were performed in triplicate.
Effect of CM from fibroblasts on the EMT of OTSCC cells
To examine the effect of CM from fibroblasts on the EMT 
of OTSCC cells, TSCCa or CAL-27 cells were seeded 
into 96-well plates at a density of 1.5 × 103 per well and 
cultured in CM from CAFs or NFs. CM from TSCCa or 
CAL-27 cells was used as a control. Total cell protein was 
collected from each plate, and the expression of epithe-
lial markers(α-catenin, β-catenin, E-cadherin)and mesen-
chymal markers (α-SMA, vimentin) was detected by ECL 
prime western blotting detection reagent (Amersham) 
according to the manufacturer’s instructions. β-actin was 
used as a loading control.
Statistical analysis
Statistical analysis was conducted with SPSS stand-
ard version 17.0 software. Data are expressed as the 
mean ± SD from at least three independent determina-
tions. The significance of the differences was analyzed 
using Student’s t tests. Differences were considered sig-
nificant at P < 0.05.
Result
The relationship between the frequency and distribution 
of CAFs and the clinicopathological characteristics 
and prognosis of patients with OTSCC
We further investigated the link between the frequency 
and distribution of CAFs and the clinicopathological char-
acteristics of patients with oral tongue cancer using a panel 
of 178 paraffin-embedded, archived oral tongue cancer 
specimens. The frequency and distribution of CAFs was 
analyzed by double immunohistochemical staining with 
an anti-α-SMA antibody and an anti-Ki67 antibody. High 
frequency and distribution of CAFs were detected in 95 
samples (53.4%) and low frequency and distribution were 
observed in 83 tumor samples (46.6%) (Figure 1a).
Statistical analysis showed a correlation between the 
frequency and distribution of CAFs as determined by 
immunohistochemistry and the clinicopathological char-
acteristics of cN0 oral tongue cancer, including patho-
logic stage (P  =  0.001), T classification (P  =  0.004), N 
classification (P  =  0.024), recurrence (P  =  0.010) and 
vital status (P  =  0.001). In contrast, the frequency and 
distribution of CAFs did not correlate with age or gender 
(Additional file 1: Table S1).
A survival analysis showed a clear negative correla-
tion between the frequency and the distribution of 
CAFs with the overall survival and the disease-free sur-
vival of patients with cN0 tongue squamous cell cancer 
(P  <  0.001, P  =  0.002, respectively) (Figure  1b). A Cox 
regression analysis revealed that only N classification 
(relative risk, 2.479, CI 1.486–4.571, P  <  0.001) and the 
frequency and distribution of CAFs (relative risk: 2.113, 
CI 1.461–3.015, P = 0.023) were independent prognostic 
factors for poor overall survival.
Isolation of CAFs and NFs
CAFs and their paired NFs were successfully isolated from 
eight primary OTSCCs by short-term primary culture in 
DMEM supplemented with 10% fetal bovine Serum. To 
confirm that CAFs derived from tumor tissue were part 
of a population of pure fibroblasts without tumor cell 
contamination, several cell markers including the epi-
thelial cell marker E-cadherin and the fibroblast marker 
fibronectin, were used to distinguish fibroblasts from 
tumor cells. In addition, the CAF-specific marker α-SMA 
was also used. The immunohistochemistry results dem-
onstrated that the CAFs expressed the fibroblast-specific 
marker fibronectin as well as the CAF-specific marker 
α-SMA. However, the NFs expressed only the fibroblast-
specific marker fibronectin, and OTSCCs expressed only 
the epithelial cell marker E-cadherin (Figure 2a). The 3-D 
cell culture showed that OTSCCs that were co-cultured 
with CAFs grew and aggregated more quickly than when 
they were co-cultured with NFs (Figure 2b).
CAFs demonstrate a stronger ability to promote the 
growth, proliferation, and mobility of OTSCC cells 
compared with NFs
The cell growth assay revealed that the cell growth rate of 
CAFs was significantly higher than that of NFs under the 
same culture conditions (P  <  0.05; Figure 3a, b). A flow 
cytometric analysis showed that the percentage of cells in 
the S and G2-M phases was significantly higher in CAFs 
compared with NFs (P < 0.05), which suggests that CAFs 
had a stronger capacity for proliferation than their paired 
NF counterparts (Figure 3c, d).
Effect of CM from CAFs
The cell growth assay showed that OTSCC cells which 
are cultured in CM from CAFs grow faster than when 
they are cultured in CM from NFs (Figure  4a, b). A 
flow cytometric analysis revealed that the S/G2 peak 
was more common in OTSCC cells grown in CM from 
CAFs compared with OTSCC cells grown in CM from 
NFs (Figure  4c, d). A cell wound healing assay showed 
that OTSCC cells grown in CM from CAFs have greater 
capacity for proliferation and mobility compared with 
OTSCC cells grown in CM from NFs (Figure  5a). A 
Transwell invasion assay both showed that OTSCC cells 
growing in CM from CAFs have greater mobility and a 
greater capacity for invasion and proliferation compared 
with OTSCC cells growing in CM from NFs (Figure 5b). 
A western blot assay showed that OTSCC cells grown 
Page 6 of 10Li et al. J Transl Med  (2015) 13:198 
in CM from CAFs expressed lower levels of epithelial 
markers (α-catenin, β-catenin, E-cadherin) but expressed 
higher levels of mesenchymal markers (α-SMA, vimen-
tin) compared with OTSCC cells grown in CM from NFs 
(Figure 5c).
Discussion
The tongue is the most cancer-prone intraoral site in 
most populations that have been studied and remains 
among the worst sites for all cancers in terms of survival 
[3]. The most common pathological type of oral tongue 
cancer is squamous cell carcinoma [2]. In clinical prac-
tice, head and neck surgeons depend primarily on the 
TNM classification system to plan treatment strategies, 
and no consensus exists on the optimal treatment of 
patients with cN0 oral tongue cancer [33]. However, the 
TNM system is not sufficiently reliable for the prediction 
of clinical outcome or for the establishment of detailed 
information on the biological characteristics of a malig-
nancy [34]. The poor prognosis of oral tongue cancer is 
mainly a consequence of its unusual histological makeup, 
which means that this cancer type is poorly equipped 
to resist invasion and metastasis [35]. Attempts have 
been made to elucidate the underlying mechanism of 
the development of oral tongue carcinoma based on the 
characteristics of the cancer cells themselves; however, 
a clear cancer-associated gene or molecular machinery 
of the pathogenesis has not yet been established. With 
the exception of the traditional therapeutic program, 
including surgery, radiotherapy and chemotherapy, drugs 
that effectively target genes have not been adequately 
developed.
Cancer, a widespread major public health threat, is 
believed to be a multistep process with numerous accu-
mulated genetic changes that occur during disease devel-
opment and progression. Recent findings that tumors do 
not act alone, but rather, are surrounded by a malignant 
microenvironment composed of the tumor-associated 
cancer stroma, which is created by and acts for the tumor 
itself, may lead to a reassessment of this concept. CAFs 
are now recognized as the main effectors of tumor needs 
in terms of angiogenesis, collagen breakdown, further 
invasion and suppression of the host immune response 
[15–17]. Marilena Vered et al. performed a triple immu-
nostaining assay in tongue squamous cell cancer with 
E-cadherin, Ki-67 and α-smooth muscle actin to identify 
Figure 2 Representative cell morphology of CAFs, NFs, and tumor cells (OTSCC). Immunofluorescence was used to distinguish CAFs, NFs and 
OTSCC cells with antibodies that target α‑SMA, fibronectin, and E‑cadherin (a). Neither CAFs nor NFs grow or aggregate in matigel. Tca8113and 
CAL‑27co‑cultured with CAFs grow and aggregate better than that with NFs (b).
Page 7 of 10Li et al. J Transl Med  (2015) 13:198 
carcinoma cells undergoing epithelial–mesenchymal 
transition. They also used a Kaplan–Meier survival analy-
sis with univariate and Cox multivariate regression mod-
els with stepwise forward selection, and Fisher’s exact 
tests to confirm that local recurrence and overall survival 
were negatively influenced by abundance of cancer stro-
mal myofibroblasts [32]. We used a panel of 178 paraf-
fin-embedded, archived oral tongue cancer specimens to 
perform double immunohistochemical staining with an 
anti-α-SMA antibody and an anti-Ki67 antibody. Statisti-
cal analysis showed a correlation between the frequency 
and distribution of CAFs, as determined by immunohis-
tochemistry and the clinicopathological characteristics of 
patients with cN0 oral tongue cancer, including patho-
logic stage, T classification, N classification, recurrence 
and vital status. A survival analysis showed a clear nega-
tive correlation of the frequency and distribution of CAFs 
with overall survival and disease-free survival in patients 
with cN0 tongue squamous cell cancer. These results are 
in agreement with those of previous studies.
One of the current evidence-based theories is that at 
least some of the CAFs actually represent malignant cells 
that have undergone epithelial–mesenchymal transfor-
mation (EMT) [36–38]. In our recent study, by WB, we 
were able to demonstrate abnormal expression of key fac-
tors of tumor cells undergoing EMT in cases of human 
tongue carcinoma. These processes might provide a rea-
sonable explanation for our observation that an abun-
dance of CAFs were found to be significantly associated 
with disease recurrence and patient survival. The present 
results are in agreement with those of studies on CAFs 
in various types of carcinomas, including pancreas [21], 
colon [22], breast [23], basal cell cancer [24] and gastric 
[39].
In the present study, we isolated and characterized 
CAFs from oral tongue squamous cancer tissue. The cell 
Figure 3 CAFs grow faster than NFs. XTT assay was used to compare cell growth rates between CAFs and NFs (a, b). Two examples of DNA content 
comparison between CAFs, NFs by flow cytometry. Flow cytometry histogram shows that the percentages of cells in S and G2‑M phases were 
significantly higher in CAFs compared with NFs (c, d).
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growth rate of CAFs was significantly higher (P  <  0.05) 
than that of paired fibroblasts from nontumor tissue. 
Flow cytometry revealed that the percentage of prolif-
erating cells (S and G2-M phases) was also significantly 
higher in CAFs than in NFs (P  <  0.05). A 3D co-cul-
ture model compared CAFs and NFs co-cultured with 
OTSCC lines. This provided a valuable tool to dissect 
the complex interactions between these cell populations 
to understand the factors that determine the behavior 
of breast cancer. These results showed the differences 
between CAFs and NFs not only in their morphologic 
appearance but also in their biological behavior, which 
may be due to genetic mutations.
Paracrine production of cytokines by CAFs has 
also been reported in multiple tumor types. High lev-
els of serum FGF2 have been observed in individu-
als with small cell lung cancer and are associated with 
a poor prognosis [40]. This may be due to an FGF2-
mediated cytoprotective effect, whereby the expres-
sion of antiapoptotic proteins is up-regulated, which 
promotes resistance to current anticancer treatments 
[41]. Increased paracrine expression of one or more 
of FGF1, 2, 4, 5, 8, and 18 has been found to promote 
tumor neoangiogenesis in preclinical models via the 
main endothelial FGFRs, FGFR1 and 2 [42]. Poor prog-
nosis has been associated with neoangiogenesis in ovar-
ian cancer and melanomas [43]. Previous studies have 
demonstrated that the potential mechanism that medi-
ates tumorigenesis and progression includes PI3 K-Akt, 
MAPK, Wnt/beta-catenin and other signaling path-
ways. Based on our study results, we have enough evi-
dence to hypothesize that some paracrine production of 
CAFs may be involved in some tumorigenic mechanism 
to achieve EMT.
Figure 4 Tca8113 and CAL‑27 in CAFs CM grow faster than in NFs CM. XTT assay was used to compare cell growth rates between Tca8113or CAL‑27 
in CAFs and NFs CM (a, b). Two examples of DNA content comparison between Tca8113 and CAL‑27 in CAFs CM, NFs CM and its own CM by flow 
cytometry. Flow cytometry histogram shows that the percentages of cells in S and G2‑M phases were significantly higher in CAFs CM compared 
with NFs and its own CM (c, d).
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Conclusions
CAFs were an independent prognostic factor for patients 
with OTSCC. Compared with NFs, CAFs and their CM 
have the ability to promote the growth, proliferation, 
migration and even EMT of OTSCC cells.
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Figure 5 CAFs promote cell mobility and invasion. a The effect of CAFs on cell migration was determined by wound‑healing assay. During a period 
of 48 h, the spreading speed of CAL‑27 in CAFs CM along the wound edge was faster than that in NFs and its own CM. b Representative images 
showed that Tca8113 and CAL‑27 in CAFs, NFs and its own CM invaded through the matrigel. The number of invaded tumour cells was quantified 
in the right panel. Columns, mean of triplicate experiments, P < 0.01. c Expressions of epithelial markers α‑catenin, β‑catenin and E‑cadherin and 
mesenchymal markers α‑SMA and vimentin were compared by western blotting analysis between Tca8113 and CAL‑27 in CAFs, NFs and its own 
CM. β‑actin was used as a loading control.
Page 10 of 10Li et al. J Transl Med  (2015) 13:198 
Acknowledgements
This study was supported by grants from the National Natural Science Foun‑
dation of China (No. 81172568).
Compliance with ethical guidelines
Competing interests
The authors declare that they have no competing interests.
Received: 24 November 2014   Accepted: 27 May 2015
References
 1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global 
cancer statistics. CA Cancer J Clin 61:69–90
 2. Moore SR, Johnson NW, Pierce AM, Wilson DF (2000) The epidemiology of 
tongue cancer: a review of global incidence. Oral Dis 6:75–84
 3. Jemal A, Clegg LX, Ward E, Ries LA, Wu X, Jamison PM et al (2004) Annual 
report to the nation on the status of cancer, 1975–2001, with a special 
feature regarding survival. Cancer 101:3–27
 4. Rodrigues‑Lisoni FC, Peitl PJ, Vidotto A, Polachini GM, Maniglia JV, 
Carmona‑Raphe J et al (2010) Genomics and proteomics approaches to 
the study of cancer‑stroma interactions. BMC Med Genomics 3:14
 5. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 
6:392–401
 6. Plzak J, Lacina L, Chovanec M, Dvorankova B, Szabo P, Cada Z et al (2010) 
Epithelial‑stromal interaction in squamous cell epithelium‑derived 
tumors: an important new player in the control of tumor biological 
properties. Anticancer Res 30:455–462
 7. Polyak K, Haviv I, Campbell IG (2009) Co‑evolution of tumor cells and 
their microenvironment. Trends Genet 25:30–38
 8. Eck SM, Cote AL, Winkelman WD, Brinckerhoff CE (2009) CXCR4 and 
matrix metalloproteinase‑1 are elevated in breast carcinoma‑associated 
fibroblasts and in normal mammary fibroblasts exposed to factors 
secreted by breast cancer cells. Mol Cancer Res 7:1033–1044
 9. Gonda TA, Varro A, Wang TC, Tycko B (2010) Molecular biology of cancer‑
associated fibroblasts: can these cells be targeted in anti‑cancer therapy? 
Semin Cell Dev Biol 21:2–10
 10. Sappino AP, Skalli O, Jackson B, Schurch W, Gabbiani G (1988) Smooth‑
muscle differentiation in stromal cells of malignant and non‑malignant 
breast tissues. Int J Cancer 41:707–712
 11. Lazard D, Sastre X, Frid MG, Glukhova MA, Thiery JP, Koteliansky VE (1993) 
Expression of smooth muscle‑specific proteins in myoepithelium and 
stromal myofibroblasts of normal and malignant human breast tissue. 
Proc Natl Acad Sci USA 90:999–1003
 12. Mueller MM, Fusenig NE (2004) Friends or foes—bipolar effects of the 
tumour stroma in cancer. Nat Rev Cancer 4:839–849
 13. Ronnov‑Jessen L, Petersen OW, Bissell MJ (1996) Cellular changes 
involved in conversion of normal to malignant breast: importance of the 
stromal reaction. Physiol Rev 76:69–125
 14. De Wever O, Mareel M (2003) Role of tissue stroma in cancer cell invasion. 
J Pathol 200:429–447
 15. Jewett A, Head C, Cacalano NA (2006) Emerging mechanisms of immu‑
nosuppression in oral cancers. J Dent Res 85:1061–1073
 16. De Wever O, Demetter P, Mareel M, Bracke M (2008) Stromal myofibro‑
blasts are drivers of invasive cancer growth. Int J Cancer 123:2229–2238
 17. Voulgari A, Pintzas A (2009) Epithelial‑mesenchymal transition in cancer 
metastasis: mechanisms, markers and strategies to overcome drug resist‑
ance in the clinic. Biochim Biophys Acta 1796:75–90
 18. Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial‑
mesenchymal transitions. Nat Rev Mol Cell Biol 7:131–142
 19. Nawshad A, Lagamba D, Polad A, Hay ED (2005) Transforming growth 
factor‑beta signaling during epithelial‑mesenchymal transformation: 
implications for embryogenesis and tumor metastasis. Cells Tissues 
Organs 179:11–23
 20. Vered M, Allon I, Buchner A, Dayan D (2009) Stromal myofibroblasts 
accompany modifications in the epithelial phenotype of tongue dysplas‑
tic and malignant lesions. Cancer Microenviron 2:49–57
 21. Friess H, Ding J, Kleeff J, Fenkell L, Rosinski JA, Guweidhi A et al (2003) 
Microarray‑based identification of differentially expressed growth‑ and 
metastasis‑associated genes in pancreatic cancer. Cell Mol Life Sci 
60:1180–1199
 22. Nakagawa H, Liyanarachchi S, Davuluri RV, Auer H, Martin EJ, de la 
Chapelle A et al (2004) Role of cancer‑associated stromal fibroblasts in 
metastatic colon cancer to the liver and their expression profiles. Onco‑
gene 23:7366–7377
 23. Singer CF, Gschwantler‑Kaulich D, Fink‑Retter A, Haas C, Hudelist G, 
Czerwenka K et al (2008) Differential gene expression profile in breast 
cancer‑derived stromal fibroblasts. Breast Cancer Res Treat 110:273–281
 24. Micke P, Kappert K, Ohshima M, Sundquist C, Scheidl S, Lindahl P et al 
(2007) in situ identification of genes regulated specifically in fibroblasts of 
human basal cell carcinoma. J Invest Dermatol 127:1516–1523
 25. Tlsty TD (2001) Stromal cells can contribute oncogenic signals. Semin 
Cancer Biol 11:97–104
 26. Elenbaas B, Weinberg RA (2001) Heterotypic signaling between epithelial 
tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 264:169–184
 27. Nakayama H, Enzan H, Miyazaki E, Naruse K, Kiyoku H, Hiroi M (1998) The 
role of myofibroblasts at the tumor border of invasive colorectal adeno‑
carcinomas. Jpn J Clin Oncol 28:615–620
 28. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR (2002) 
Reactive stroma in human prostate cancer: induction of myofibroblast phe‑
notype and extracellular matrix remodeling. Clin Cancer Res 8:2912–2923
 29. Orimo A, Tomioka Y, Shimizu Y, Sato M, Oigawa S, Kamata K et al (2001) 
Cancer‑associated myofibroblasts possess various factors to promote 
endometrial tumor progression. Clin Cancer Res 7:3097–3105
 30. Nouraee N, Van Roosbroeck K, Vasei M, Semnani S, Samaei NM, Naghsh‑
var F et al (2013) Expression, tissue distribution and function of miR‑21 in 
esophageal squamous cell carcinoma. PLoS One 8(9):e73009
 31. Thompson L (2006) World Health Organization classification of tumours: 
pathology and genetics of head and neck tumours. Ear Nose Throat J 85:74
 32. Vered M, Dobriyan A, Dayan D, Yahalom R, Talmi YP, Bedrin L et al (2010) 
Tumor‑host histopathologic variables, stromal myofibroblasts and risk 
score, are significantly associated with recurrent disease in tongue can‑
cer. Cancer Sci 101:274–280
 33. D’Cruz AK, Siddachari RC, Walvekar RR, Pantvaidya GH, Chaukar DA, 
Deshpande MS et al (2009) Elective neck dissection for the management 
of the N0 neck in early cancer of the oral tongue: need for a randomized 
controlled trial. Head Neck 31:618–624
 34. Hayry V, Makinen LK, Atula T, Sariola H, Makitie A, Leivo I et al (2010) Bmi‑1 
expression predicts prognosis in squamous cell carcinoma of the tongue. 
Br J Cancer 102:892–897
 35. Manning BD, Cantley LC (2007) AKT/PKB signaling: navigating down‑
stream. Cell 129:1261–1274
 36. Guarino M (2007) Epithelial‑mesenchymal transition and tumour inva‑
sion. Int J Biochem Cell Biol 39:2153–2160
 37. Yang J, Weinberg RA (2008) Epithelial‑mesenchymal transition: at the 
crossroads of development and tumor metastasis. Dev Cell 14:818–829
 38. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED et al 
(2007) Epithelial–mesenchymal and mesenchymal–epithelial transitions 
in carcinoma progression. J Cell Physiol 213:374–383
 39. Zhi K, Shen X, Zhang H, Bi J (2010) Cancer‑associated fibroblasts are 
positively correlated with metastatic potential of human gastric cancers. J 
Exp Clin Cancer Res 29:66
 40. Ruotsalainen T, Joensuu H, Mattson K, Salven P (2002) High pretreatment 
serum concentration of basic fibroblast growth factor is a predictor of 
poor prognosis in small cell lung cancer. Cancer Epidemiol Biomarkers 
Prev 11:1492–1495
 41. Pardo OE, Wellbrock C, Khanzada UK, Aubert M, Arozarena I, Davidson 
S et al (2006) FGF‑2 protects small cell lung cancer cells from apopto‑
sis through a complex involving PKCepsilon, B‑Raf and S6K2. EMBO J 
25:3078–3088
 42. Presta M, Dell’Era P, Mitola S, Moroni E, Ronca R, Rusnati M (2005) 
Fibroblast growth factor/fibroblast growth factor receptor system in 
angiogenesis. Cytokine Growth Factor Rev 16:159–178
 43. Birrer MJ, Johnson ME, Hao K, Wong KK, Park DC, Bell A et al (2007) Whole 
genome oligonucleotide‑based array comparative genomic hybridiza‑
tion analysis identified fibroblast growth factor 1 as a prognostic marker 
for advanced‑stage serous ovarian adenocarcinomas. J Clin Oncol 
25:2281–2287
